MEDTR FINANCIAL STATEMENTS

Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi — balance sheet, income statement and cash flow trends

MEDTRMeditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi

🇹🇷 Turkey · IS · Healthcare · Medical Devices

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue2.9 B ₺+6.5%

Gross Profit901.6 M ₺-11.5%

Operating Income84.1 M ₺-62.3%

EBITDA273.3 M ₺-22.3%

Net Income5.8 M ₺-62.9%

Peer Comparison· Medical Devices

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
MEDTR	6.5%	30.9%	9.4%	0.2%
OM	2.0%	40.6%	-48.6%	-63.7%
NNOX	25.7%	-87.7%	-336.6%	-523.8%
LUNG	1.2%	75.5%	-54.5%	-60.1%
MXCT	-14.3%	80.7%	-107.3%	-121.2%
TELA	13.5%	67.3%	-40.2%	-49.3%
Industry median	7.4%	58.9%	5.2%	-5.7%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity3.2 B ₺83%
Current Liabilities530.7 M ₺14%
Long-term Liabilities117.9 M ₺3%

Key Figures

YoY change

Total Assets3.8 B ₺+27.0%

Total Liabilities648.6 M ₺+7.8%

Total Equity3.2 B ₺+31.8%

Cash & ST Investments480.1 M ₺+24.2%

Total Debt31.5 M ₺-23.2%

Net Debt-400.5 M ₺—

Peer Comparison· Medical Devices

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
MEDTR	3.58	1.0%	-1.64	83.0%
OM	6.29	91.0%	0.96	44.8%
NNOX	3.64	6.0%	0.74	86.6%
LUNG	4.91	123.0%	0.11	38.1%
MXCT	12.04	10.4%	-0.08	86.3%
TELA	3.61	-1,084.3%	-0.52	-7.4%
Industry median	3.28	44.7%	0.82	49.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow615.8 M ₺-29.4%

Capital Expenditures-191.4 M ₺—

Free Cash Flow814.3 M ₺-24.3%

Dividends Paid-37.8 M ₺—

Peer Comparison· Medical Devices

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
MEDTR	21.1%	27.9%	6.6%	10,700.8%
OM	-28.5%	-29.1%	0.6%	44.8%
NNOX	-313.5%	-351.8%	38.3%	59.8%
LUNG	-33.1%	-33.3%	0.2%	55.1%
MXCT	-87.2%	-91.4%	4.1%	72.0%
TELA	-36.7%	-37.4%	0.7%	74.5%
Industry median	7.2%	1.5%	4.1%	76.6%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on MEDTR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.